Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC
PZ HTL SA

Next-Generation Gas Chromatograph and GC/MSD Enable New Levels of Performance

By BiotechDaily International staff writers
Posted on 12 Feb 2013
Image: The new Agilent 5977A Series GC/MSD, including the new 7890B GC (adjacent at right) (Photo courtesy of Agilent).
Image: The new Agilent 5977A Series GC/MSD, including the new 7890B GC (adjacent at right) (Photo courtesy of Agilent).
A new gas chromatograph (GC) and a mass selective detector to function with the GC offer a broad, feature-rich portfolio, and enable superior levels of sensitivity, reliability, and productivity.

Agilent Technologies (Santa Clara, CA, USA) introduces the Agilent 7890B gas chromatograph and the 5977A Series GC/MSD (mass selective detector) to offer the industry's broadest, feature-rich portfolio of superior performance GC, GC/MSD, and related software. Agilent also offers factory-tested, preconfigured solutions to help fast-track setup and operation. "Customers will find significant product improvements, eco-friendly capabilities, and lower cost of ownership, along with unsurpassed performance,” said Monty Benefiel, Agilent vice president for Gas Phase Systems.

Based on the known reliability of the Agilent GC platform, the new 7890B GC is faster, easier to operate, and more cost-effective. The 7890B GC features Improved performance specifications with advances in numerous detector modules; Lower operating costs and ecofriendly operation with power/gas management and sleep/wake modes; Seamless ordering of consumables and parts with an interactive graphical Parts Finder tool and consumables database; Easier, faster method development with integrated GC calculators and wizards; Better asset and resource management with integrated maintenance tools; Improved recovery of active compounds with Agilent's exclusive end-to-end Inert Flow Path deactivation technology; Reduced downtime for MS maintenance using the new Fast Vent feature.

The Agilent 7890B GC runs on Agilent OpenLAB Chromatography Data System software. The new Agilent OpenLAB CDS is up to 40 times faster than previous versions, with a new Data Analysis package and Intelligent Reporting. Advanced interactive integration tools and graphical displays accelerate data review, reducing time-to-results and freeing up operators for other tasks. "Our customers require the means to efficiently and accurately analyze their data as well as information about their laboratory assets to support decision making or gain further scientific insight. OpenLAB does all of that," said Bruce von Herrmann, Agilent vice president for Software and Informatics. "With streamlined workflows and complete data and method migration from ChemStation and EZChrom, OpenLAB is a fully scalable solution for a single laboratory, multiple workgroups, and entire enterprises."

The Agilent 5977A Series GC/MSD provides all the benefits of the 7890B GC plus features a redesigned inert MS ion source that enhances performance with highly efficient ion collection. The 5977A Series GC/MSD now offers the highest sensitivity on the market, with a new specification metric, the Instrument Detection Limit, for system-level performance in practice. Using Agilent's TwisTorr 304 FS turbomolecular vacuum pump, optimized for light gas operation, the new 5977A GC/MSD system is efficient and rugged, and has been evaluated and certified to meet Agilent’s leading quality standards. The GC/MSD runs on Agilent MassHunter Workstation software solution for high-throughput MS data analysis, and also includes a full version of MSD ChemStation to ensure compatibility with previously purchased instruments.

Related Links:
Agilent Technologies, Inc.
Agilent 7890B GC and 5977A Series GC/MSD
Agilent Inert Flow Path Solutions



BIOSIGMA S.R.L.
SLAS - Society for Laboratory Automation and Screening
RANDOX LABORATORIES
comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: A 3-dimensional picture reveals how the antibodies in the experimental drug Zmapp bind to Ebola virus (Photo courtesy of the Scripps Research Institute).

Electron Microscope Imaging Shows How Experimental Anti-Ebola Drug Works

Electron microscope imaging has revealed how the experimental drug ZMapp binds to the Ebolavirus and provides insights into how the drug prevents growth of the pathogen. ZMapp, which was developed by... Read more

Drug Discovery

view channel

Omega 3 Found to Improve Behavior in Children with ADHD

Supplements of the fatty acids omega 3 and 6 can help children and adolescents who have a specific kind of have attention deficit hyperactivity disorder (ADHD). Moreover, these findings indicate that a customized cognitive training program can improve problem behavior in children with ADHD. Statistics show that 3%–6%... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

Two Industry Partnerships Initiated to Fuel Neuroscience Research

Faster, more complex neural research is now attainable by combining technology from two research companies. Blackrock Microsystems, LLC (Salt Lake City, UT, USA), a developer of neuroscience research equipment, announced partnerships with two neuroscience research firms—PhenoSys, GmbH (Berlin, Germany) and NAN Instruments, Ltd.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.